Locations
San Francisco, CA, USA
industry
Biotechnology · Data and Analytics · DeepTech · Health · Software
Size
11-50 employees
Stage
Other
founded in
2016
Darmiyan is a pioneering company focused on brain health, utilizing advanced AI and medical imaging to detect neurodegenerative diseases like Alzheimer's at early stages. Their flagship product, Brain See, is FDA-approved and combines MRI data with cognitive assessments to provide a prognosis score for patients with mild cognitive impairment. The technology is built on over 40 years of neuroscience research and aims to revolutionize brain health diagnostics and monitoring, making it accessible and non-invasive for patients and healthcare providers alike. With a strong emphasis on accuracy and integration, Darmiyan is positioned to significantly impact the healthcare landscape for brain diseases.
Something looks off?